- Home
- GRAL vs IRMD Comparison
GRAL vs IRMD Comparison
Compare GRAL & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAL
- IRMD
- Stock Information
- Founded
- GRAL 2016
- IRMD 1992
- Country
- GRAL United States
- IRMD United States
- Employees
- GRAL N/A
- IRMD N/A
- Industry
- GRAL
- IRMD Medical/Dental Instruments
- Sector
- GRAL
- IRMD Health Care
- Exchange
- GRAL NYSE
- IRMD Nasdaq
- Market Cap
- GRAL 1.6B
- IRMD 756.5M
- IPO Year
- GRAL N/A
- IRMD 2014
- Fundamental
- Price
- GRAL $41.07
- IRMD $58.02
- Analyst Decision
- GRAL Buy
- IRMD Strong Buy
- Analyst Count
- GRAL 3
- IRMD 1
- Target Price
- GRAL $31.50
- IRMD $72.00
- AVG Volume (30 Days)
- GRAL 1.4M
- IRMD 68.7K
- Earning Date
- GRAL 08-12-2025
- IRMD 07-31-2025
- Dividend Yield
- GRAL N/A
- IRMD 1.14%
- EPS Growth
- GRAL N/A
- IRMD 10.72
- EPS
- GRAL N/A
- IRMD 1.55
- Revenue
- GRAL $130,711,000.00
- IRMD $75,154,639.00
- Revenue This Year
- GRAL $19.52
- IRMD $10.62
- Revenue Next Year
- GRAL $20.37
- IRMD $9.69
- P/E Ratio
- GRAL N/A
- IRMD $37.15
- Revenue Growth
- GRAL 30.47
- IRMD 11.04
- 52 Week Low
- GRAL $12.33
- IRMD $42.34
- 52 Week High
- GRAL $63.99
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- GRAL N/A
- IRMD 46.18
- Support Level
- GRAL N/A
- IRMD $58.44
- Resistance Level
- GRAL N/A
- IRMD $60.85
- Average True Range (ATR)
- GRAL 0.00
- IRMD 1.62
- MACD
- GRAL 0.00
- IRMD -0.40
- Stochastic Oscillator
- GRAL 0.00
- IRMD 8.87
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.